KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,020 | -25.1% | 3,000 | 0.0% | 0.00% | – |
Q2 2023 | $5,370 | -54.0% | 3,000 | 0.0% | 0.00% | – |
Q1 2023 | $11,670 | +14.4% | 3,000 | 0.0% | 0.00% | – |
Q4 2022 | $10,200 | -36.2% | 3,000 | 0.0% | 0.00% | – |
Q3 2022 | $16,000 | +14.3% | 3,000 | 0.0% | 0.00% | – |
Q2 2022 | $14,000 | -50.0% | 3,000 | -21.1% | 0.00% | – |
Q1 2022 | $28,000 | +16.7% | 3,800 | 0.0% | 0.00% | – |
Q4 2021 | $24,000 | +9.1% | 3,800 | 0.0% | 0.00% | – |
Q3 2021 | $22,000 | -43.6% | 3,800 | 0.0% | 0.00% | – |
Q2 2021 | $39,000 | -78.2% | 3,800 | -77.7% | 0.00% | – |
Q1 2021 | $179,000 | -31.9% | 17,010 | 0.0% | 0.00% | – |
Q4 2020 | $263,000 | +378.2% | 17,010 | +347.6% | 0.00% | – |
Q3 2020 | $55,000 | -23.6% | 3,800 | 0.0% | 0.00% | – |
Q2 2020 | $72,000 | -1.4% | 3,800 | 0.0% | 0.00% | – |
Q1 2020 | $73,000 | 0.0% | 3,800 | 0.0% | 0.00% | – |
Q4 2019 | $73,000 | +97.3% | 3,800 | 0.0% | 0.00% | – |
Q3 2019 | $37,000 | +60.9% | 3,800 | 0.0% | 0.00% | – |
Q2 2019 | $23,000 | +4.5% | 3,800 | 0.0% | 0.00% | – |
Q1 2019 | $22,000 | -38.9% | 3,800 | 0.0% | 0.00% | – |
Q4 2018 | $36,000 | +300.0% | 3,800 | +660.0% | 0.00% | – |
Q3 2018 | $9,000 | +12.5% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |